Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023

Hozzl · 2024-07-10T08:05:15Z

Explore the details of House Bill 5074 Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

7/10/2024, 8:05 AM

Congressional Summary of HR 5074

Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 or the Kidney PATIENT Act of 2023

This bill delays a change to the payment methodology under Medicare for oral drugs that are used to treat end-stage renal disease (ESRD).

Under current regulations, beginning January 1, 2025, the Centers for Medicare & Medicaid Services will incorporate payments for oral-only ESRD drugs into the ESRD prospective payment system rather than issuing separate payments to ESRD facilities. The bill delays implementation of this policy until January 1, 2033, or until an approved intravenous drug is available, whichever is earlier.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5074

Bill HR 5074 is currently in the status of Bill Introduced since July 28, 2023. Bill HR 5074 was introduced during Congress 118 and was introduced to the House on July 28, 2023. Bill HR 5074's most recent activity was Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I. as of June 11, 2024

Bipartisan Support of Bill HR 5074

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5074

Primary Policy Focus

Health

Potential Impact Areas

- Digestive and metabolic diseases

- Health care costs and insurance

- Medicare

- Prescription drugs

Alternate Title(s) of Bill HR 5074

Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023

Kidney PATIENT Act of 2023

Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023

To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.